Immunogenicity & Immunotoxicity
Immunotherapeutics & Immunomonitoring
Cytokines & Inflammation
GTCbio is proud to present the 9th Immunotherapeutics & Immunomonitoring Conference, to be held on February 6-7, 2017 in San Diego, CA.
The immune system plays a central role not only in fighting infections, but also in many diseases and medical conditions, including cancer. Studies of the immune system has led to significant findings in many fields of medicine and biology, which has yielded the discovery of novel and unique substances and reagents that are now widely used for diagnosing, evaluating, and treating different malignant diseases. The development of prophylactic and therapeutic vaccines, and innovative combinatorial immunotherapeutic approaches, has substantially decreased mortality, increased life expectancy, improved life expectancy and improved the well-being of the millions of patients.
Leading scientific and clinical experts from academia and industry will present the latest findings and developments in the exciting area of immunotherapeutics and immunomonitoring. New immunological concepts with clinically translational implications will be discussed, along with evaluations of novel drug targets and therapeutic approaches, the role of biomarkers in immunomonitoring, and the latest data on combinatorial treatments in the clinic.
Network with colleagues to discuss updates on state-of-the-art immunomonitoring, novel strategies to identify and validate biomarkers predictive for clinical efficacy, novel strategies to identify and clinically develop synergistic combination therapies, and the outlook on novel druggable targets for immunotherapy.
I. Emerging Targets in Immune Therapeutics
II. Conditioning the Tumor Microenviroment for Immunotherapy
III. Immunomonitoring & Novel High Throughput Technologies
IV. Combination Immunotherap
We hope to see you there!
The 2017 Organizing Committee
What Past Delegates said:
“The GTC conference definitely provided a private, common, and friendly setting to exchange ideas and opinions with industry and academia leaders. Networking really happens at this conference with relevant and exciting topics. I left the GTC conference with fresh ideas and with new connections for future partnerships.” – Mario Pulido, PhD Student, USC
“The topics covered in the 4th Immunotherapeutics and Immunomonitoring Conference were targeted and provided an excellent balance between clinical and basic research. Moreover, the intimate setting was an ideal environment to foster collaboration.” – Fatema Legrand, Associate Director, Clinical Immunology, BN Immunotherapeutics
“The GTC Immunotherapeutics Summit was a great opportunity to meet industry and academic leaders. The networking opportunities were ideal for meaningful exchanges and setting up potential collaborations.” – Yoav Peretz Ph.D., Principal Scientist, ImmuneCarta Services
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com